Transcutaneous immunization using colonization factor and heat-labile enterotoxin induces correlates of protective immunity for enterotoxigenic Escherichia coli

Infection and Immunity

Volumn 70, Issue 3, 2002, Pages 1056-1068

  Yu, Jianmei ^a   Cassels, Frederick ^a   Scharton Kersten, Tanya ^a   Hammond, Scott A ^a   Hartman, Antoinette ^a   Angov, Evelina ^a   Corthésy, Blaise ^a   Alving, Carl ^a   Glenn, Gregory ^a  

^a IOMAI Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIARRHEAL AGENT; ANTIPARASITIC AGENT; CHOLERA TOXIN; ESCHERICHIA COLI ENTEROTOXIN; ESCHERICHIA COLI VACCINE; HEAT LABILE ENTEROTOXIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOLOGICAL ADJUVANT; MALARIA VACCINE; MEMBRANE PROTEIN; MEROZOITE SURFACE PROTEIN 1; MEROZOITE SURFACE PROTEIN ANTIBODY; PROTEIN ANTIBODY; RECOMBINANT COLONIZATION FACTOR CS6; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ANTIGEN RECOGNITION; ARTICLE; BACTERIAL COLONIZATION; BLOOD CHEMISTRY; CONTROLLED STUDY; CORRELATION ANALYSIS; DIARRHEA; DRUG DELIVERY SYSTEM; DRUG FORMULATION; ESCHERICHIA COLI; FECES ANALYSIS; FEMALE; GUINEA PIG; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOMODULATION; IMMUNOTHERAPY; MOUSE; NONHUMAN; PARASITOSIS; PRIORITY JOURNAL; PROTEIN INDUCTION; T LYMPHOCYTE ACTIVATION; TOXIN ANALYSIS; TRAVELLER DIARRHEA; VACCINATION; VACCINE PRODUCTION;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, CUTANEOUS; ANIMALS; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; ANTIGENS, SURFACE; BACTERIAL PROTEINS; BACTERIAL TOXINS; DIARRHEA; ENTEROTOXINS; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI PROTEINS; ESCHERICHIA COLI VACCINES; FECES; FEMALE; GUINEA PIGS; IMMUNIZATION, PASSIVE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; LUNG; MALARIA VACCINES; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MUCOUS MEMBRANE; VAGINA;

EID: 0036178064     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.70.3.1056-1068.2002     Document Type: Article

References (51)

1. Long-term mortality follow-up of Army recruits who received adjuvant influenza virus vaccine in 1951-1953
2. Immunization onto bare skin with heat-labile enterotoxin of Escherichia coli enhances immune responses to coadministered protein and peptide antigens and protects mice against lethal toxin challenge
3. Epidemiology of diarrhoeal disease: Implications for control by vaccines
4. Analysis of Escherichia coli colonization factor antigen I linear B-cell epitopes, as determined by primate responses, following protein sequence verification
5. Colonization factors of diarrheagenic E. coli and their intestinal receptors
6. Cross protection by B subunit-whole cell cholera vaccine against diarrhea associated with heat-labile toxin-producing enterotoxigenic Escherichia coli: Results of a large-scale field trial
7. Properties of homogeneous heat-labile enterotoxin from Escherichia coli
8. Safety and immunogenicity of two different lots of the oral, killed enterotoxigenic Escherichia coli-cholera toxin B subunit vaccine in Israeli young adults
9. Preparation of the vascular permeability factor of Vibrio cholerae
10. Risk of diarrhea during the first year of life associated with initial and subsequent colonization by specific enteropathogens
11. Expression, purification and biochemical characterization of recombinant murine secretory component: A novel tool in mucosal immunology
12. Immunopotentiating reconstituted influenza virosomes as a novel antigen delivery system
13. Vaccine adjuvants
14. Transcutaneous immunisation with herpes simplex virus stimulates immunity in mice
15. Non-replicating oral whole cell vaccine protective against enterotoxigenic Escherichia coli (ETEC) diarrhea: Stimulation of anti-CFA (CFA/I) and anti-enterotoxin (anti-LT) intestinal IgA and protection against challenge with ETEC belonging to heterologous serotypes
16. Hemagglutination of human group A erythrocytes by enterotoxigenic Escherichia coli isolated from adults with diarrhea: Correlation with colonization factor
17. Milk immunoglobulin with specific activity against purified colonization factor antigens can protect against oral challenge with enterotoxigenic Escherichia coli
18. Bacterial toxins as mucosal adjuvants
19. Antitoxic immunity in experimental cholera: A comparison of immunity induced perorally and parenterally in mice
20. Escherichia coli. EAEC, EHEC, EIEC, ETEC
21. Skin immunization made possible by cholera toxin
22. Transcutaneous immunization with cholera toxin protects mice against lethal mucosal toxin challenge
23. Transcutaneous immunization with bacterial ADP-ribosylating exotoxins as antigens and adjuvants
24. Transcutaneous immunization: A human vaccine delivery strategy using a patch
25. Transcutaneous immunization induces mucosal and systemic immunity: A potent method for targeting immunity to the female reproductive tract
26. Transcutaneous immunization of domestic animals: Opportunities and challenges
27. Transcutaneous immunization: T-cell responses and boosting of existing immunity
28. Local immune response and protection in the guinea pig keratoconjunctivitis model following immunization with shigella vaccines
29. Native and mutant forms of cholera toxin and heat-labile enterotoxin effectively enhance protective efficacy of live attenuated and heat-killed Shigella vaccines
30. Binding of enterotoxigenic Escherichia coli to isolated enterocytes and intestinal mucus
31. Safety, immunogenicity, and efficacy of a malaria sporozoite vaccine administered with monophosphoryl lipid A, cell wall skeleton of mycobacteria, and squalane as adjuvant
32. Adverse reactions to tetanus toxoid
33. Pilot evaluation of influenza virus vaccine (IVV) combined with adjuvant
34. New knowledge on pathogenesis of bacterial enteric infections as applied to vaccine development
35. Immunity to enterotoxigenic Escherichia coli
36. Oral immunization with urease and Escherichia coli heat-labile enterotoxin is safe and immunogenic in Helicobacter pylori-infected adults
37. Enterotoxigenic Escherichia coli (ETEC) in farm animals
38. Enterotoxigenic Escherichia coli diarrhea in children less than five years of age in central Java
39. Antitoxic immunity to cholera in dogs immunized orally with cholera toxin
40. Protection against experimental cholera by antitoxin
41. Immunity to experimental cholera. I. Protective effect of humoral IgG antitoxin demonstrated by passive immunization
42. Sealed adult mice: New model for enterotoxin evaluation
43. Tricine-sodium dodecyl sulfatepolyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa
44. Transcutaneous immunization with bacterial ADP-ribosylating exotoxins, subunits, and unrelated adjuvants
45. Effect of DETOX as an adjuvant for melanoma vaccine
46. Lack of prophylactic efficacy of an enteric-coated bovine hyperimmune milk product against enterotoxigenic Escherichia coli challenge administered during a standard meal
47. Occurrence, distribution, and associations of O and H serogroups, colonization factor antigens, and toxins of enterotoxigenic Escherichia coli
48. The CS6 colonization factor of human enterotoxigenic Escherichia coli contains two heterologous major subunits
49. Characterization of enterotoxigenic Escherichia coli isolated from U.S. troops deployed to the Middle East